Reach Banner
Last name



This is a "connection" page, showing publications co-authored by David Malkin and Donald Mabbott.

Connection Strength
  1. de Medeiros CB, Moxon-Emre I, Scantlebury N, Malkin D, Ramaswamy V, Decker A, Law N, Kumabe T, Leonard J, Rubin J, Jung S, Kim SK, Gupta N, Weiss W, Faria CC, Vibhakar R, Lafay-Cousin L, Chan J, Kros JM, Janzen L, Taylor MD, Bouffet E, Mabbott DJ. Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort. Cancer Med. 2020 01; 9(2):447-459.
    View in: PubMed
    Score: 0.219
  2. Oyefiade A, Erdman L, Goldenberg A, Malkin D, Bouffet E, Taylor MD, Ramaswamy V, Scantlebury N, Law N, Mabbott DJ. PPAR and GST polymorphisms may predict changes in intellectual functioning in medulloblastoma survivors. J Neurooncol. 2019 Mar; 142(1):39-48.
    View in: PubMed
    Score: 0.206
  3. Moxon-Emre I, Taylor MD, Bouffet E, Hardy K, Campen CJ, Malkin D, Hawkins C, Laperriere N, Ramaswamy V, Bartels U, Scantlebury N, Janzen L, Law N, Walsh KS, Mabbott DJ. Intellectual Outcome in Molecular Subgroups of Medulloblastoma. J Clin Oncol. 2016 12; 34(34):4161-4170.
    View in: PubMed
    Score: 0.177
  4. Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Sharpe MB, Laughlin S, Bartels U, Scantlebury N, Law N, Malkin D, Skocic J, Richard L, Mabbott DJ. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma. J Neurosurg Pediatr. 2016 Jul; 18(1):29-40.
    View in: PubMed
    Score: 0.170
  5. Law N, Smith ML, Greenberg M, Bouffet E, Taylor MD, Laughlin S, Malkin D, Liu F, Moxon-Emre I, Scantlebury N, Mabbott D. Executive function in paediatric medulloblastoma: The role of cerebrocerebellar connections. J Neuropsychol. 2017 06; 11(2):174-200.
    View in: PubMed
    Score: 0.163
  6. Law N, Greenberg M, Bouffet E, Laughlin S, Taylor MD, Malkin D, Liu F, Moxon-Emre I, Scantlebury N, Skocic J, Mabbott D. Visualization and segmentation of reciprocal cerebrocerebellar pathways in the healthy and injured brain. Hum Brain Mapp. 2015 Jul; 36(7):2615-28.
    View in: PubMed
    Score: 0.159
  7. Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol. 2014 Jun 10; 32(17):1760-8.
    View in: PubMed
    Score: 0.147
  8. Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM. Medulloblastoma. Nat Rev Dis Primers. 2019 02 14; 5(1):11.
    View in: PubMed
    Score: 0.052
  9. Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA. How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma. Patient Prefer Adherence. 2018; 12:2103-2110.
    View in: PubMed
    Score: 0.051
  10. Khakban A, Mohammadi T, Lynd LD, Mabbott D, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor M, Marra CA. Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of life. Pediatr Blood Cancer. 2017 06; 64(6).
    View in: PubMed
    Score: 0.045
  11. Henrich N, Marra CA, Gastonguay L, Mabbott D, Malkin D, Fryer C, Bouffet E, Taylor MD, Hukin J, Scantlebury N, Lynd L. De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival. Pediatr Blood Cancer. 2014 Jul; 61(7):1300-4.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.